Marc Van Ranst Selected Research

Marc Van Ranst Research Topics

Disease

20	Infections 01/2021 - 07/2004
7	COVID-19 05/2022 - 01/2020
6	Gastroenteritis 11/2021 - 11/2009
3	Hantavirus Infections 01/2021 - 01/2006
3	Neoplasms (Cancer) 09/2019 - 06/2006
3	Human Influenza (Influenza) 12/2015 - 10/2010
3	Disease Progression 06/2015 - 01/2006
3	Papilloma (Papillomatosis) 10/2013 - 11/2004
3	Chronic Hepatitis C 11/2007 - 02/2006
2	Glioma (Gliomas) 01/2021 - 10/2020
2	Malaria 01/2021 - 10/2004
2	Fibrosis (Cirrhosis) 06/2014 - 03/2010
2	Rotavirus Infections 11/2010 - 12/2009
2	Diarrhea 11/2008 - 01/2007
2	Severe Acute Respiratory Syndrome 04/2005 - 07/2004
1	Coinfection 11/2021
1	Bruton type agammaglobulinemia 01/2021
1	Congenital Abnormalities (Deformity) 12/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Dyspepsia (Indigestion) 01/2016
1	Lactose Intolerance (Intolerance, Lactose) 09/2015
1	Hepatocellular Carcinoma (Hepatoma) 06/2014
1	HIV Seropositivity 01/2014
1	Hepatitis B 10/2010
1	Chronic Hepatitis B 03/2010
1	Hepatitis 09/2009
1	Body Weight (Weight, Body) 08/2009
1	Myocarditis (Carditis) 06/2008
1	Substance-Related Disorders (Drug Abuse) 11/2007
1	Condylomata Acuminata (Genital Wart) 07/2007
1	Delusional Parasitosis 04/2007
1	Basosquamous Carcinoma 10/2006
1	Feline Infectious Peritonitis 03/2006
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2006
1	Astrocytoma (Pilocytic Astrocytoma) 07/2005
1	Crohn Disease (Crohn's Disease) 07/2005
1	Progressive Multifocal Leukoencephalopathy 07/2005
1	Hemorrhagic Cystitis 01/2005
1	Acute malaria 10/2004
1	Viremia 10/2004

Drug/Important Bio-Agent (IBA)

10	Antiviral Agents (Antivirals)IBA 01/2021 - 07/2004
8	VaccinesIBA 04/2016 - 11/2004
6	AntigensIBA 01/2021 - 01/2007
4	Rotavirus VaccinesIBA 11/2021 - 12/2009
4	Pharmaceutical PreparationsIBA 01/2021 - 10/2004
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2009
4	InterferonsIBA 11/2020 - 02/2006
4	DNA (Deoxyribonucleic Acid)IBA 12/2014 - 06/2006
3	AntibodiesIBA 05/2022 - 11/2020
3	Chloroquine (Aralen)FDA LinkGeneric 01/2021 - 10/2004
3	RNA (Ribonucleic Acid)IBA 01/2018 - 04/2005
2	Viral RNAIBA 03/2022 - 04/2005
2	Immunoglobulin G (IgG)IBA 01/2021 - 11/2020
2	NucleoproteinsIBA 11/2020 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 07/2005
2	Formaldehyde (Formol)FDA Link 07/2013 - 06/2006
2	ParaffinIBA 07/2013 - 06/2006
2	NucleotidesIBA 03/2010 - 01/2006
2	Ribavirin (Virazole)FDA LinkGeneric 04/2007 - 02/2006
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	SARS-CoV-2 spike proteinIBA 11/2020
1	Gold Colloid (Colloidal Gold)IBA 01/2020
1	NestinIBA 09/2019
1	Viral ProteinsIBA 01/2018
1	Drinking WaterIBA 01/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	CytokinesIBA 01/2016
1	HydrogenIBA 09/2015
1	LactaseIBA 09/2015
1	Lactose FDA LinkGeneric 09/2015
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 06/2015
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	ImmunosorbentsIBA 06/2014
1	arylesteraseIBA 06/2014
1	Conjugated (USP) Estrogens (Premarin)FDA Link 06/2014
1	Keratins (Keratin)IBA 07/2013
1	RotaTeqIBA 12/2009
1	RIX4414 vaccineIBA 12/2009
1	Indicators and Reagents (Reagents)IBA 01/2009
1	pyridine N-oxideIBA 03/2006
1	GuanineIBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	Adenine FDA LinkGeneric 01/2006
1	Natalizumab (Tysabri)FDA Link 07/2005
1	IntegrinsIBA 07/2005
1	A-factor (Streptomyces)IBA 04/2005
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2005
1	Cidofovir (Vistide)FDA Link 01/2005
1	Antimalarials (Antimalarial Agents)IBA 10/2004

Therapy/Procedure

6	Therapeutics 11/2020 - 01/2005
2	Radiotherapy 01/2021 - 10/2020
1	Home Nursing (Nursing, Home) 04/2022
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Fetal Therapies (Fetal Therapy) 12/2020
1	Radioimmunotherapy 10/2020
1	Retention in Care 01/2014
1	Immunotherapy 10/2010
1	Intravenous Administration 01/2005
1	Intravesical Administration 01/2005
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2005